Literature DB >> 8544026

Tumor osteolysis in osteopetrotic mice.

D R Clohisy1, C M Ogilvie, M L Ramnaraine.   

Abstract

Details of the cellular and biochemical mechanisms involved in focal destruction of bone at sites of tumor osteolysis are unknown. It has been shown that tumors from sarcoma (2472) cell lines induce focal osteolysis in mice by stimulating formation and activation of osteoclasts. In this report, the influence of 2472 tumors on the skeletons of osteoclast-deficient animals (op/op) was studied. After op/op femora had been inoculated with 2472 cells, tumors developed and focal osteolysis occurred. There were more osteoclasts per histologic section in sham-injected femora (19 +/- 5) than in tumor-bearing femora (412 +/- 129) (p < 0.05). The size of the osteoclasts also increased from 304 +/- 81 microns 2 in sham-injected limbs to 407 +/- 62 microns 2 in tumor-bearing limbs (p < 0.001). Conditioned media from 2472 op/op tumor explants contained macrophage colony-stimulating factor. A deficiency of osteoclasts in op/op mice is the result of the absence of this factor; therefore, these data introduce the possibility that macrophage colony-stimulating factor derived from 2472 tumor may be responsible for directing osteoclast-mediated osteolysis at sites of the tumor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8544026     DOI: 10.1002/jor.1100130613

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  13 in total

Review 1.  Mechanism of cancer pain.

Authors:  Brian L Schmidt; Darryl T Hamamoto; Donald A Simone; George L Wilcox
Journal:  Mol Interv       Date:  2010-06

2.  Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain.

Authors:  M J Schwei; P Honore; S D Rogers; J L Salak-Johnson; M P Finke; M L Ramnaraine; D R Clohisy; P W Mantyh
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

3.  Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation.

Authors:  Kader Yagiz; Susan R Rittling
Journal:  Exp Cell Res       Date:  2009-05-08       Impact factor: 3.905

4.  LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis.

Authors:  E W Thompson; V Sung; M Lavigne; K Baumann; N Azumi; A D Aaron; R Clarke
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

5.  Analgesic effects of nonsteroidal antiinflammatory drugs, acetaminophen, and morphine in a mouse model of bone cancer pain.

Authors:  Osamu Saito; Tomohiko Aoe; Tatsuo Yamamoto
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

6.  Ewing's sarcoma of bone tumor cells produces MCSF that stimulates monocyte proliferation in a novel mouse model of Ewing's sarcoma of bone.

Authors:  B S Margulies; S D DeBoyace; T A Damron; M J Allen
Journal:  Bone       Date:  2015-06-05       Impact factor: 4.398

7.  Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer.

Authors:  Tamara King; Anna Vardanyan; Lisa Majuta; Ohannes Melemedjian; Ray Nagle; Anne E Cress; Todd W Vanderah; Josephine Lai; Frank Porreca
Journal:  Pain       Date:  2007-08-15       Impact factor: 6.961

8.  A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain.

Authors:  Iryna A Khasabova; Sergey G Khasabov; Catherine Harding-Rose; Lia G Coicou; Bryan A Seybold; Amy E Lindberg; Christopher D Steevens; Donald A Simone; Virginia S Seybold
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

9.  NGF blockade at early times during bone cancer development attenuates bone destruction and increases limb use.

Authors:  Gwen McCaffrey; Michelle L Thompson; Lisa Majuta; Michelle N Fealk; Stephane Chartier; Geraldine Longo; Patrick W Mantyh
Journal:  Cancer Res       Date:  2014-10-06       Impact factor: 12.701

10.  Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain.

Authors:  Jean-Marc G Guedon; Geraldine Longo; Lisa A Majuta; Michelle L Thomspon; Michelle N Fealk; Patrick W Mantyh
Journal:  Pain       Date:  2016-06       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.